Preeclampsia Screening Panel: Comprehensive Early Detection
Understanding Preeclampsia and Its Importance
Preeclampsia is a serious pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, most often the liver and kidneys. This condition typically begins after 20 weeks of pregnancy in women whose blood pressure had previously been normal. The Preeclampsia Screening Panel represents a significant advancement in prenatal care, offering early detection capabilities that can dramatically improve pregnancy outcomes.
This specialized screening test is performed between 10-13 weeks gestation, providing crucial information that enables healthcare providers to implement preventive measures and close monitoring for at-risk pregnancies. Early identification of preeclampsia risk allows for timely interventions that can significantly reduce maternal and fetal complications.
What the Preeclampsia Screening Panel Measures
Our comprehensive screening panel utilizes advanced ECLIA (Electrochemiluminescence Immunoassay) methodology to measure two critical biomarkers:
Placental Growth Factor (PlGF)
PlGF is a protein that plays a vital role in placental development and function. Low levels of PlGF have been strongly associated with impaired placental development and increased risk of preeclampsia.
Pregnancy Associated Plasma Protein A (PAPP-A)
PAPP-A is a protein produced by the placenta during pregnancy. Abnormal levels of PAPP-A can indicate placental dysfunction and are linked to an increased risk of developing preeclampsia.
Who Should Consider This Screening Test
The Preeclampsia Screening Panel is recommended for all pregnant women, particularly those with:
- First pregnancy
- History of preeclampsia in previous pregnancies
- Family history of preeclampsia
- Pre-existing hypertension or kidney disease
- Diabetes (pre-existing or gestational)
- Multiple pregnancy (twins or more)
- Obesity (BMI over 30)
- Age over 35 years
- Autoimmune disorders
Key Benefits of Early Preeclampsia Screening
Early detection through our screening panel offers numerous advantages:
- Proactive Management: Identifies at-risk pregnancies early, allowing for closer monitoring and preventive measures
- Reduced Complications: Early intervention can significantly decrease the risk of severe preeclampsia and associated complications
- Personalized Care: Enables healthcare providers to tailor prenatal care based on individual risk assessment
- Peace of Mind: Provides reassurance for low-risk pregnancies and appropriate vigilance for higher-risk cases
- Cost-Effective: Early detection can prevent costly hospitalizations and intensive care requirements
Understanding Your Test Results
Your Preeclampsia Screening Panel results will provide a comprehensive risk assessment:
Low Risk Results
A low-risk result indicates that your current biomarker levels suggest minimal risk for developing preeclampsia. However, continued routine prenatal care and monitoring remain essential throughout your pregnancy.
Increased Risk Results
If your screening indicates an increased risk, your healthcare provider will develop a personalized management plan that may include:
- More frequent prenatal visits
- Additional blood pressure monitoring
- Regular urine protein testing
- Possible low-dose aspirin therapy (as recommended by your physician)
- Increased fetal monitoring
Important Considerations
It’s crucial to understand that screening tests assess probability, not certainty. A positive screening result doesn’t guarantee you will develop preeclampsia, and a negative result doesn’t completely eliminate the possibility. Regular prenatal care remains essential regardless of screening results.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $112 |
| Regular Price | $176 |
Test Specifications
- Turnaround Time: Sample collection Tuesday/Thursday/Saturday by 9 AM, Report Same Day
- Sample Type: 2 mL (1 mL minimum) serum from 1 SST
- Sample Handling: Ship refrigerated or frozen
- Valid Testing Window: 10-13 weeks gestation
Required Information for Testing
To ensure accurate results, the following information must be provided:
- Maternal Date of Birth (DD/MM/YY)
- Height and Weight
- IVF Status
- Smoking Status
- History of Blood Pressure
- Diabetes History
- Pre-eclampsia in Previous Pregnancy
- Number of Fetuses (Single/Twins)
- Blood Pressure Measurements for Right & Left Arm
- Ultrasound for CRL & Uterine Artery PI
- Duly Filled Pre-eclampsia Screening Form (Form 13)
Nationwide Availability
GGC DNA has testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our extensive network ensures accessible prenatal screening services for expectant mothers nationwide.
Take Action for Your Pregnancy Health
Don’t wait to get the essential information you need for a healthy pregnancy. Early detection of preeclampsia risk can make a significant difference in your pregnancy outcome. Our experienced team and state-of-the-art facilities are ready to provide you with accurate, reliable screening results.
Book your Preeclampsia Screening Panel today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the proactive step toward ensuring the best possible outcome for you and your baby.
Our compassionate healthcare professionals understand the importance of this screening and are committed to providing you with the highest quality care and support throughout your pregnancy journey.
